Prospect News: News for Ondine Biopharma Corp.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with O > Issuers starting with O, PP only > All stories on Ondine Biopharma Corp. > Stories on Ondine Biopharma Corp., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Ondine Biopharma Corp.

5/19/2009	PP	New Issue: Ondine arranges C$1.78 million share exchange with Grafton Resource
5/19/2009	PP	Market Commentary: Hemispherx arranges offering; Cytokinetics to raise $14 million; Ondine plans equity exchange
1/23/2009	PP	Market Commentary: Dia Bras upsizes deal, could look for more; Ondine, AnaeCo sell stock; International Stem Cell sells more
1/23/2009	PP	New Issue: Ondine arranges C$1.02 million private placement of shares
12/10/2007	PP	New Issue: Ondine Biopharma sells upsized C$6.97 million offering of units
12/10/2007	PP	Market Commentary: Underground Solutions sells $12.5 million; Andean plans C$5 million; Mint won't sell C$6 million
11/26/2007	PP	New Issue: Ondine Biopharma plans C$5.5 million private placement of units

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.